Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Sales | 1,121 | 705 | 676 | 790 | 652 |
| Cost of Goods | 0 | 464 | 439 | 517 | 0 |
| Gross Profit | 449 | 241 | 237 | 273 | 652 |
| Operating Expenses | 3,761 | 2,546 | 1,718 | 1,770 | 0 |
| Operating Income | -2,640 | -2,305 | -1,481 | -1,497 | 652 |
| Interest Expense | 0 | 52 | 54 | 54 | 0 |
| Pre-tax Income | -2,640 | -2,357 | -1,535 | -1,551 | 652 |
| Net Income Continuous | -4,027 | -2,357 | -1,535 | -1,551 | -1,383 |
| Net Income | $-4,027 | $-2,357 | $-1,535 | $-1,551 | $-1,383 |
| EPS Basic Total Ops | -2.96 | -1.88 | -1.28 | -1.40 | -1.40 |
| EPS Basic Continuous Ops | -2.95 | -1.87 | -1.26 | -1.40 | -1.41 |
| EPS Diluted Total Ops | -2.96 | -1.88 | -1.28 | -1.40 | -1.40 |
| EPS Diluted Continuous Ops | -2.95 | -1.87 | -1.26 | -1.40 | -1.41 |
| EBITDA(a) | $-2,385 | $-2,298 | $-1,474 | $-1,416 | $652 |